Humans Positron Emission Tomography Computed Tomography / methods Small Cell Lung Carcinoma / diagnostic imaging Retrospective Studies Fluorodeoxyglucose F18 Gallium Radioisotopes Lymphatic Metastasis Lung Neoplasms / diagnostic imaging Neoplasm Staging
68Ga-OPS-202 68Ga-SSO-120 PET SCLC SSTR

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2023
Historique:
received: 06 03 2023
revised: 24 05 2023
medline: 5 10 2023
pubmed: 21 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

PET imaging using the somatostatin receptor 2 (SSTR2) antagonist satoreotide trizoxetan (SSO-120, previously OPS-202) could offer accurate tumor detection and screening for SSTR2-antagonist radionuclide therapy in patients with SSTR2-expressing small cell lung cancer (SCLC). The aim of this single-center study was to investigate tumor uptake and detection rates of

Identifiants

DOI: 10.2967/jnumed.123.265664 PMID: 37474272
pubmed: 37474272
pii: jnumed.123.265664
doi: 10.2967/jnumed.123.265664
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D
Gallium Radioisotopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1540-1549

Informations de copyright

© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

David Kersting (D)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; david.kersting@uni-due.de.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Patrick Sandach (P)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Miriam Sraieb (M)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Marcel Wiesweg (M)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Martin Metzenmacher (M)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Kaid Darwiche (K)

Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Filiz Oezkan (F)

Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Servet Bölükbas (S)

Department of Thoracic Surgery and Thoracic Endoscopy, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Martin Stuschke (M)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Lale Umutlu (L)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Institute of Diagnostic and Interventional Radiology and Neuroradiology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; and.

Michael Nader (M)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Rainer Hamacher (R)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Johannes Wienker (J)

Department of Pulmonary Medicine, Section of Interventional Pulmonology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.
Division of Thoracic Oncology, West German Lung Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Wilfried E E Eberhardt (WEE)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Division of Thoracic Oncology, West German Lung Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Martin Schuler (M)

German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Division of Thoracic Oncology, West German Lung Center, University Medicine Essen-Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany.

Ken Herrmann (K)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Hubertus Hautzel (H)

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains ›
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie ›
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Tumeurs des bronches › Carcinome bronchogénique › Carcinome pulmonaire à petites cellules ›
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives ›
questionsmedicales.fr › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 ›
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Gallium › Isotopes du gallium › Radio-isotopes du gallium ›
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Métastase lymphatique ›
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon ›
questionsmedicales.fr › Diagnostic › Pronostic › Stadification tumorale ›